EVICR.net statement for the Clinical Sites on the management of clinical trials during the pandemic.

The health and well-being of patients and clinical team remain the most relevant concern for everyone. It is therefore essential to follow the clear recommendations of the World Health Organization, the EMA guidelines, the respective governments and local authorities and the Sponsor’s specific instructions for the study to minimize the risks of COVID-19 transmission.